ROLE OF ANTIBIOTIC STEWARDSHIP PROGRAM IN IMPROVING RATIONAL THIRD-LINE ANTIBIOTIC USE IN TYPE-2 DM INPATIENTS AT FATMAWATI HOSPITAL

Rizky Farmasita Budiastuti

Abstract


Type-2 diabetes mellitus (T2DM) is the most common metabolic disorders, caused by a combination of two factors: damaged insulin secretion by pancreatic β-cell and the inability of insulin-sensitive tissues to respond appropriately to insulin. Epidemiological data reveal alarming values that predict a concerning future for T2DM. According to the International Diabetes Federation (IDF), in 2019, diabetes caused 4.2 million deaths, and 463 million adults aged between 20-79 years old were living with diabetes, a number that is projected to increase up to 700 million by 2045. Based on data from RISKESDAS in 2018, the prevalence of DM in Indonesia has increased from 6.9% in 2013 to 8.5% in 2018. The Antimicrobial Resistance Control Program (PPRA) team is essential in the development and implementation of evidence-based guidelines and policies. The purpose of this study was to determine the profile of patients receiving antibiotic therapy and the use of third-line antibiotics in T2DM patients at Fatmawati Hospital during the July-December 2021 period. This research used a retrospective descriptive design with a non-experimental approach. The sample size consisted of 52 medical records that met the inclusion criteria. The results showed that patients receiving the most antibiotic treatment were between the ages of 55-64 years (38.5%), women (52%), and those with diabetic foot complications (51.8%). The single and most used combination antibiotics were ampicillin-sulbactam (34.7%) and ampicillin-sulbactam+metronidazole (29.2%). 28.8% of the patients were recommended to receive third-line antibiotics and received considerations from the PPRA team, of which 73.33% obtained approval.

Keywords


type-2 diabetes mellitus; T2DM; rationality; antibiotics; PPRA

References


World Health Organization. Diagnosis and management of type 2 diabetes (HEARTS-D). Geneva; 2020.

American Diabetes Association (ADA). Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care [Internet]. 2021 Jan 1 [cited 2025 Jun 6];44(Suppl 1):S15–33. Available from: https://pubmed.ncbi.nlm.nih.gov/33298413/

Agency of Health Research and Development (Indonesia). Indonesia Basic Health Research 2018 [Internet]. Jakarta; 2018 [cited 2025 Jun 6]. Available from: https://ghdx.healthdata.org/record/indonesia-basic-health-research-2018

Uçkay I, Aragón-Sánchez J, Lew D, Lipsky BA. Diabetic foot infections: What have we learned in the last 30 years? International Journal of Infectious Diseases [Internet]. 2015 Nov 1 [cited 2025 Jun 6];40:81–91. Available from: https://pubmed.ncbi.nlm.nih.gov/26460089/

Meirita K, Sari Y. Evaluation of Combination Antibiotic Use in Treating Surgical Site Infections at XYZ Hospital. Journal of Health Science and Prevention. 2022;6(1):10–6.

Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev [Internet]. 2019 Oct 28 [cited 2025 Jun 6];16(5):442–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31657690/

Lansang MC, Zhou K, Korytkowski MT. Inpatient Hyperglycemia and Transitions of Care: A Systematic Review. Endocrine Practice [Internet]. 2021 Apr 1 [cited 2025 Jun 6];27(4):370–7. Available from: https://pubmed.ncbi.nlm.nih.gov/33529732/

Direktorat Jenderal Farmasi dan Alat Kesehatan. Pedoman Umum Penggunaan Antibiotik [Internet]. 2013 [cited 2025 Jun 6]. Available from: https://farmalkes.kemkes.go.id/unduh/buku-pedoman-penggunaan-antibiotik/

Dinas Kesehatan Provinsi Maluku Utara S, Hi Mustafa IA, Purnomo W, Umbul CW. DETERMINAN EPIDEMIOLOGIS KEJADIAN ULKUS KAKI DIABETIK PADA PENDERITA DIABETES MELLITUS DI RSUD Dr. CHASAN BOESOIRIE DAN DIABETES CENTER TERNATE. Jurnal Wiyata: Penelitian Sains dan Kesehatan [Internet]. 2017 May 25 [cited 2025 Jun 6];3(1):54–60. Available from: https://ojs.iik.ac.id/index.php/wiyata/article/view/71

Lathifah NL. The Relationship between Duration Disease and Blood Glucose related to Subjective Compliance in Diabetes Mellitus. Jurnal Berkala Epidemiologi. 2017;5.

Millah M. Evaluasi penggunaan antibiotik pada pasien diabetes mellitus dengan ulkus diabetikum di RSI Siti Hajar Sidoarjo periode 2016. Universitas Islam Negeri Maulana Malik Ibrahim; 2018.

Fitria E, Nur A, Marissa N, Nur Ramadhan Loka Litbang Biomedis Aceh Jl Sultan Iskandar Muda Blang Bintang Lr Tgk Dilangga No dan, Besar Indonesia A. Karakteristik Ulkus Diabetikum pada Penderita Diabetes Mellitus di RSUD Dr. Zainal Abidin dan RSUD Meuraxa Banda Aceh. Buletin Penelitian Kesehatan [Internet]. 2017 Nov 17 [cited 2025 Jun 6];45(3):153–60. Available from: https://www.neliti.com/id/publications/197276/

Suba Z, Barabás J, Takács D, Szabó G, Ujpál M. Epidemiological correlations of insulin resistance and salivary gland tumors. Orv Hetil [Internet]. 2005 Aug 1 [cited 2025 Jun 6];146(33):1727–32. Available from: https://europepmc.org/article/med/16206887

Permana H. Komplikasi kronik dan penyakit penyerta pada diabetes. [Bandung]: Hasan Sadikin Hospital; 2009.

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol [Internet]. 2018 Jun 8 [cited 2025 Jun 6];17(1). Available from: https://pubmed.ncbi.nlm.nih.gov/29884191/

Abohelwa M, Kopel J, Shurmur S, Ansari MM, Awasthi Y, Awasthi S. The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review. Journal of Vascular Diseases 2023, Vol 2, Pages 122-164 [Internet]. 2023 Feb 16 [cited 2025 Jun 6];2(1):122–64. Available from: https://www.mdpi.com/2813-2475/2/1/10/htm

Corina. Profil Komplikasi Kronis Pada Pasien Diabetes Melitus Tipe II Di Poli Endokrin RSUD Dr. Soetomo Periode Juli-September 2017. - Penelusuran Google [Internet]. [Surabaya]: Airlangga University; 2018 [cited 2025 Jun 6]. Available from: https://www.google.com/search?q=Corina.+(2018).+Profil+Komplikasi+Kronis+Pada+Pasien+Diabetes+Melitus+Tipe+II+Di+Poli+Endokrin+RSUD+Dr.+Soetomo+Periode+Juli-September+2017.&rlz=1C5CHFA_enID968ID968&oq=Corina.+(2018).+Profil+Komplikasi+Kronis+Pada+Pasien+Diabetes+Melitus+Tipe+II+Di+Poli+Endokrin+RSUD+Dr.+Soetomo+Periode+Juli-September+2017.&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIHCAEQIRiPAjIHCAIQIRiPAjIHCAMQIRiPAtIBBzgxNWowajSoAgCwAgE&sourceid=chrome&ie=UTF-8

Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: An epidemiological study. Crit Care [Internet]. 2009 Feb 13 [cited 2025 Jun 6];13(1). Available from: https://pubmed.ncbi.nlm.nih.gov/19216780/

Costantini E, Carlin M, Porta M, Brizzi MF. Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence. Acta Diabetol [Internet]. 2021 Sep 1 [cited 2025 Jun 6];58(9):1139–51. Available from: https://pubmed.ncbi.nlm.nih.gov/33973089/

Anggriani Y (Yusi), Restinia M (Mita), Mitakda VC (Venessya), Rochsismandoko R (Rochsismandoko), Kusumaeni T (Tri). Clinical Outcomes of Antibiotic Use on Patients of Diabetic Foot Infection. Jurnal Sains Farmasi dan Klinis [Internet]. 2015 [cited 2025 Jun 6];1(2):111–21. Available from: https://www.neliti.com/id/publications/128763/

Meirita E, Sari A. Evaluation of Antibiotics Usage Rationality on Diabetes Mellitus Type-2 Patients at Inpatient Installation of Grandmed Hospital Lubuk Pakam in 2022. JURNAL FARMASIMED (JFM) [Internet]. 2022 Oct 31 [cited 2025 Jun 6];5(1):73–9. Available from: https://www.researchgate.net/publication/365260663_EVALUATION_OF_ANTIBIOTICS_USAGE_RATIONALITY_ON_DIABETES_MELLITUS_TYPE_II_PATIENTS_AT_INPATIENT_INSTALLATION_OF_GRANDMED_HOSPITAL_LUBUK_PAKAM_IN_2022

Kannan I, Premavathy RK, Sambandam C, Jayalakshmi M, Sruthi PS, Shantha S. Isolation and antibiotic susceptibility of bacteria from foot infections in the patients with diabetes mellitus type I and type II in the district of Kancheepuram, Tamil Nadu, India | International Journal of Research in Medical Sciences. International Journal of Research in Medical Sciences [Internet]. 2017 Jan [cited 2025 Jun 6];2(2):457–61. Available from: https://www.msjonline.org/index.php/ijrms/article/view/2176

Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 12th ed. San Francisco: McGraw-Hill; 2012.

Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, et al. 2012 infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases [Internet]. 2012 Jun 15 [cited 2025 Jun 6];54(12). Available from: https://pubmed.ncbi.nlm.nih.gov/22619242/

Ningsih NK, Setyawati T. Perbandingan Efektivitas Antibiotik (Ciprofloxacin, Cefotaxime, Ampicillin, Ceftazidime dan Meropenem) Terhadap Bakteri Staphylococcus Aureus Penyebab Ulkus Diabetik Dengan Menggunakan Metode Kiirby-Bauer. Medika Tadulako, Jurnal Ilmiah Kedokteran. 2016;3(2).

Utami ER. Antibiotika, Resistensi, dan Rasionalitas Terapi. Sainstis [Internet]. 2012 Apr 23 [cited 2025 Jun 6]; Available from: https://www.researchgate.net/publication/265579606_ANTIBIOTIKA_RESISTENSI_DAN_RASIONALITAS_TERAPI

Dellinger RP, Levy M, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med [Internet]. 2013 [cited 2025 Jun 6];41(2):580–637. Available from: https://journals.lww.com/ccmjournal/fulltext/2013/02000/surviving_sepsis_campaign__international.24.aspx




DOI: https://doi.org/10.52447/scpij.v10i2.8397

Refbacks

  • There are currently no refbacks.